Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vaxxas starts operations with $A15mm Series A financing

Executive Summary

Start-up Vaxxas Pty. Ltd. (silicone patch technology) is being launched with a $A15mm ($16mm) Series A round from Australian and international venture capitalists led by OneVentures and including Brandon Capital, the Medical Research Commercialization Fund (managed by Brandon Capital), Brisbane Angels, and HealthCare Ventures. UniQuest Pty. Ltd., the tech transfer arm of the University of Queensland, negotiated the financing.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Transdermal
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies